Repligen (RGEN) Posts Q4 Loss of 1c/Share
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $144.24 +0.21%
EPS Growth %: +21.6%
Financial Fact:
Selling, general and administrative: 7.13M
Today's EPS Names:
CCEL, FEIM, PLG, More
EPS Growth %: +21.6%
Financial Fact:
Selling, general and administrative: 7.13M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q4 EPS of ($0.01), $0.05 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $15.4 million versus the consensus estimate of $14.7 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
- Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
- UBS Starts Cartrade Tech Ltd (CARTRADE:IN) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
